10.1152/ajpendo.00418.2014 67
Virtual Convenience, Real Results: Your safety comes first
As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance
Curb cravings and support a healthy metabolism with Akkermansia, a GLP-1 boosting probiotic to promote a healthy digestive system
Sameer Murali, MD, medical director of obesity medicine at Memorial Hermann Health System Dr
